Organicell Regenerative Medicine, Inc.
7595 SW 33rd Street, Suite 246
Davie, Florida, 33314
October 20, 2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 “F” Street, N.E.
Washington, D.C. 20549-3629
Attention: Mr. Gregory Herbers
Re: Organicell Regenerative Medicine, Inc. (the Company”)
Registration Statement on Form S-1
File No. 333-267563
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, the Company respectfully requests that the effective date of the Registration Statement is accelerated so that it will become effective at 4:00 p.m. Eastern Time on Monday, October 24, 2022, or as soon thereafter as practicable.
If you have any further questions or comments, kindly contact the undersigned at (310) 200-9741 or our counsel, Dale S. Bergman, Esq. at (305) 495-4157.
Very truly yours,
ORGANICELL REGENERATIVE MEDICINE, INC.
| By: | /s/ Ian Bothwell | |
| Ian Bothwell, Chief Financial Officer |
